Caricamento...
NI-22 NON-ENHANCING TUMOR RESPONSE USING QUANTITATIVE T2 MAPS PREDICTS SURVIVAL IN GLIOBLASTOMA TREATED WITH BEVACIZUMAB
BACKGROUND: Malignant gliomas are known to contain proportions of both neovascularized and infiltrative, non-enhancing tumor (NET). Additionally, a substantial proportion of treated tumors can have NET progression prior to contrast enhancement. There remains significant need for objective evaluation...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218347/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou264.21 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|